Real‐life impact of tenofovir disoproxil fumarate and entecavir therapy on lipid profile, glucose, and uric acid in chronic hepatitis B patients

恩替卡韦 医学 内科学 尿酸 甘油三酯 胃肠病学 混淆 代谢综合征 脂质代谢 胆固醇 内分泌学 慢性肝炎 肥胖 免疫学 拉米夫定 病毒
作者
Qi Zhang,Jinlin Liang,Junhua Yin,Yiyue Jiang,Ning Yu,Xingmei Liao,Siru Zhao,Leyuan Wu,Rong Fan
出处
期刊:Journal of Medical Virology [Wiley]
卷期号:94 (11): 5465-5474 被引量:6
标识
DOI:10.1002/jmv.27977
摘要

The impact of long-term nucleos(t)ide analogs treatment on host metabolism is a concern. Hence, we conducted this study to compare the effect of entecavir (ETV) and tenofovir disoproxil fumarate (TDF) on metabolic parameters among chronic hepatitis B (CHB) patients. In this real-life retrospective study, 2030 CHB outpatients treated with ETV or TDF at Nanfang Hospital, China, were included. For treatment-naïve patients, pretreatment and semiannual metabolic parameters were collected. For treatment-experienced patients, metabolic parameters were collected at the first visit. Propensity score matching (PSM) was used to balance the effects of potential confounding factors. Among 122 treatment-naïve patients and 1908 treatment-experienced patients, ETV-treated patients were older with a higher percentage of metabolic syndrome. After PSM, the characteristics were comparable between the two groups. For treatment-naïve patients, four lipid parameters, including total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein, and triglyceride levels showed a decreasing trend during the 42-month TDF treatment, while they remained relatively stable or increased during ETV treatment. At Month 30, the levels of TC and LDL among TDF-treated patients were significantly lower than those among ETV-treated patients (TC: 4.7 mmol/L vs. 3.9 mmol/L, p = 0.004; LDL: 3.0 mmol/L vs. 2.4 mmol/L, p = 0.009). For treatment-experienced patients, we also observed lower levels of lipid parameters in patients with different durations of TDF treatment. The levels of glucose and uric acid were similar among ETV- and TDF-treated patients. TDF has a lipid-lowering effect in CHB patients, which provides a basis for the selection of antiviral drugs for aging CHB patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
羊蛋儿发布了新的文献求助10
2秒前
2秒前
3秒前
zhq发布了新的文献求助10
3秒前
情怀应助Ayuyu采纳,获得10
5秒前
5秒前
YJ888发布了新的文献求助10
6秒前
王紫青完成签到,获得积分10
6秒前
672发布了新的文献求助10
7秒前
Agq完成签到,获得积分10
8秒前
彭于晏应助学术菜鸡123采纳,获得30
9秒前
9秒前
SciGPT应助科研通管家采纳,获得10
9秒前
Orange应助科研通管家采纳,获得10
10秒前
星辰大海应助科研通管家采纳,获得10
10秒前
科研通AI2S应助科研通管家采纳,获得10
10秒前
10秒前
所所应助科研通管家采纳,获得10
10秒前
JamesPei应助科研通管家采纳,获得10
10秒前
10秒前
yizhiGao应助科研通管家采纳,获得10
10秒前
科目三应助科研通管家采纳,获得10
10秒前
10秒前
ding应助fei采纳,获得10
11秒前
落叶完成签到,获得积分10
12秒前
yydragen应助可爱无招采纳,获得50
13秒前
slx发布了新的文献求助10
14秒前
科研通AI2S应助机智的水风采纳,获得10
14秒前
叮当发布了新的文献求助10
14秒前
haha发布了新的文献求助50
16秒前
孙燕应助keyun采纳,获得10
17秒前
hjy完成签到 ,获得积分10
18秒前
CipherSage应助落叶采纳,获得10
21秒前
修辛发布了新的文献求助10
22秒前
23秒前
荣和完成签到,获得积分10
23秒前
23秒前
FashionBoy应助Lenacici采纳,获得10
24秒前
杜兰特发布了新的文献求助10
25秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989550
求助须知:如何正确求助?哪些是违规求助? 3531774
关于积分的说明 11254747
捐赠科研通 3270278
什么是DOI,文献DOI怎么找? 1804966
邀请新用户注册赠送积分活动 882125
科研通“疑难数据库(出版商)”最低求助积分说明 809176